COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT03316586
Brief Title: A Phase II Study of Nivolumab in Combination With Cabozantinib for Metastatic Triple-negative Breast Cancer

First Submitted : October 18, 2017
First Submitted that Met QC Criteria : October 18, 2017
First Posted : October 20, 2017

Last Update Submitted that Met QC Criteria : July 5, 2019
Last Update Posted : July 8, 2019